v3.26.1
Document and Entity Information - USD ($)
 12 Months Ended
Dec. 31, 2025
Mar. 26, 2026
Jun. 30, 2025
Document and Entity Information      
Document Type 10-K    
Document Annual Report true    
Document Period End Date Dec. 31, 2025    
Document Transition Report false    
Entity File Number 001-36279    
Entity Registrant Name TVARDI THERAPEUTICS, INC.    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 75-3175693    
Entity Address, Address Line One 3 Sugar Creek Ctr. Blvd.    
Entity Address, Adress Line Two Suite 525    
Entity Address, City or Town Sugar Land    
Entity Address State Or Province TX    
Entity Address, Postal Zip Code 77478    
City Area Code 713    
Local Phone Number 489-8654    
Title of 12(b) Security Common Stock, par value $0.001 per share    
Trading Symbol TVRD    
Security Exchange Name NASDAQ    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company false    
ICFR Auditor Attestation Flag false    
Document Financial Statement Error Correction [Flag] false    
Entity Shell Company false    
Entity Public Float     $ 207,163,961
Entity Common Stock, Shares Outstanding   9,381,344  
Documents Incorporated by Reference [Text Block]

Portions of the registrant’s Proxy Statement for its 2026 Annual Meeting of Stockholders, to be filed with the Securities and Exchange Commission no later than 120 days after December 31, 2025, are incorporated by reference in Part III of this Annual Report on Form 10-K.

    
Entity Central Index Key 0001346830    
Current Fiscal Year End Date --12-31    
Document Fiscal Year Focus 2025    
Document Fiscal Period Focus FY    
Amendment Flag false    
Auditor Name Deloitte & Touche LLP    
Auditor Location Houston, Texas    
Auditor Firm ID 34